Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness meets wearable tech in a new bid to break the smoking habit

NCT ID NCT07789496

Symptom relief Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This pilot study tests a smoking cessation approach that combines mindful smoking practice with a smartphone-based sensor-band. Adults who smoke at least five cigarettes a day will be randomly assigned to either receive the mindful smoking intervention plus standard quitting information, or just the information. Over eight weeks, participants in the intervention group will practice mindful smoking when cravings hit, using the RAIN method (Recognize, Accept, Investigate, Note) while the sensor-band tracks heart rate and other body signals. The study measures whether this approach is feasible and acceptable, and looks at early signs of quitting success.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindful smoking practice using the RAIN method and a smartphone-based sensor-band
What this could lead to
If this approach works, it could offer a new, non-drug way to help people quit smoking by combining mindfulness with real-time body feedback.
What could go wrong
This is a small pilot study focused on feasibility, not proof of effectiveness. The intervention may not lead to lasting abstinence, and results may not apply to a larger population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years and older * Smoking at least 5 cigarettes per day on average over the past 3 months * Motivated to quit smoking, indicated by answering "yes" to being interested in quitting smoking or making a quit attempt in the next 30 days * Has a functioning Android or iOS smartphone * Has a telephone number available for contact Exclusion Criteria: * Recent change in the dosage or type of new medications, if taking medications, or unstable medical situation in the past 3 months * Active substance dependence other than nicotine * Use of other non-cigarette tobacco products, including e-cigarettes, more than 15 days per month * Another household member enrolled in the study * Participation in a smoking cessation program in the past 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cigarette smoking are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cigarette Smoking nicotine dependence Smoking Cessation Tobacco Use Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cigarette smoking Nicotine dependence Smoking cessation Tobacco use

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Minnesota School of Nursing

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.